The American Heart Association reveals that viral infections such as Covid-19 and the flu can significantly raise your risk ...

Gilead Sciences ( ($GILD) ) has released its Q3 earnings. Here is a breakdown of the information Gilead Sciences presented to its investors.

Explore Gilead Sciences' Q3 2025 earnings: strong HIV portfolio growth, Yeztugo's rapid launch, and raised guidance.

Funding cuts from federal programs threaten HIV care in Columbia as PALSS fights to keep vital health, housing, and food ...

Richard says it took two days for a qualified interpreter to arrive and explain he had been given the all-clear. "If an ...

Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...

GLAAD--the world's largest lesbian, gay, bisexual, transgender, and queer (LGBTQ) media advocacy organization––invited Snoop ...

Clade I, the version of mpox now circulating in Southern California, is not new to science. It’s been responsible for severe ...

SHILLONG: National People’s Party (NPP)-chi dilenggipa MDA 2.0 sorkari, MLA-rangko brena gita an·tangtangni gam-jinrangko jakkalenga ine All India Congress Committee (AICC) matnangataha. Sorkariko ...

Two owners of Cambridge-based Safe Chain Solutions have been found guilty of multiple charges including introducing black ...

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

More than 230 people became infected with HIV in Indiana, worsened by delayed action from former Gov. Mike Pence. Experts and ...